NOG:NYSENorthern Oil and Gas, Inc. Analysis
Data as of 2026-06-01 - not real-time
$21.77
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Northern Oil and Gas (NOG) is trading at $21.77, hovering just above the computed support of $21.12 and well below its 20‑day, 50‑day and 200‑day moving averages, indicating a short‑term price weakness. The RSI of 32.5 suggests the stock is approaching oversold territory, while the MACD remains bearish, reinforcing a cautious technical outlook. On the fundamentals side, revenue has slipped 7% year‑over‑year and operating margins are deeply negative, yet the company reports a strong gross margin of 74% and a positive EBITDA of $1.45 bn. Forward earnings are projected to turn positive (EPS $4.15) and the forward P/E of 5.25 is dramatically below the industry average of 20.5, creating a compelling valuation gap highlighted by a DCF fair value of $100.71 and an upside potential of roughly 58%. The dividend yield of 8.27% is attractive, but a payout ratio exceeding 460% of earnings raises serious sustainability concerns.
Looking ahead, analysts maintain a “buy” consensus with a median price target near $35, reflecting confidence in a turnaround despite the company’s $2.55 bn debt load and a debt‑to‑equity ratio above 140. High 30‑day volatility (≈46%) and a modest beta suggest price swings are likely, while sector‑specific regulatory and commodity risks remain medium. Given the blend of value‑oriented pricing, expected earnings recovery, and significant downside risks, the stock is best viewed as undervalued but speculative, warranting a measured approach to positioning.
Looking ahead, analysts maintain a “buy” consensus with a median price target near $35, reflecting confidence in a turnaround despite the company’s $2.55 bn debt load and a debt‑to‑equity ratio above 140. High 30‑day volatility (≈46%) and a modest beta suggest price swings are likely, while sector‑specific regulatory and commodity risks remain medium. Given the blend of value‑oriented pricing, expected earnings recovery, and significant downside risks, the stock is best viewed as undervalued but speculative, warranting a measured approach to positioning.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- High dividend yield but unsustainable payout
- Price near technical support with bearish MACD
- Elevated short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Forward EPS forecast turning positive
- Forward P/E far below industry average
- Analyst consensus and price targets indicating upside
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF fair value suggests deep undervaluation
- Potential debt reduction as cash flow improves
- Long‑run commodity price recovery in the energy sector
Key Metrics & Analysis
Financial Health
Revenue Growth-7.10%
Profit Margin-32.36%
P/E Ratio5.2
ROE-29.77%
ROA4.31%
Debt/Equity142.99
P/B Ratio1.3
Op. Cash Flow$1.4B
Free Cash Flow$-13380500
Industry P/E20.5
Technical Analysis
TrendNeutral
RSI32.5
Support$21.12
Resistance$27.23
MA 20$23.95
MA 50$26.18
MA 200$24.61
MACDBearish
VolumeIncreasing
Fear & Greed Index93.13
Valuation
Fair Value$100.71
Target Price$34.44
Upside/Downside58.22%
GradeUndervalued
TypeBlend
Dividend Yield8.27%
Risk Assessment
Beta0.18
Volatility45.93%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.